Westlake Village BioPartners has launched a pair of funds totalling $500m targeting life sciences companies with transformative human therapeutic technologies.
Westlake Village BioPartners has launched a pair of funds totalling $500m targeting life sciences companies with transformative human therapeutic technologies.